Fig. 4

Neoadjuvant VSVd51-miR-199 does not improve survival the BALB/c-4 T1 mouse model of TNBC. (a) Experimental timeline. (b) Kaplan-Meier curve representing survival odds across time and comparing mice treated with VSVd51-shNTC (n = 7) or VSVd51-miR-199 (n = 7). Log-rank Mantel-Cox test (ns p > 0.05).